Question 1

How many shares of CLDX does UBS Group AG own?

Accepted Answer

As of 2026-Q2, UBS Group AG holds 481,997 shares of CLDX (Celldex Therapeutics, Inc.).

Question 2

What is UBS Group AG's CLDX position worth?

Accepted Answer

As of 2026-Q2, UBS Group AG's CLDX position is worth $17.9M.

Question 3

Is UBS Group AG buying or selling CLDX?

Accepted Answer

In 2026-Q2, UBS Group AG increased their CLDX position (+62.3% change in shares).

Question 4

When did UBS Group AG first buy CLDX?

Accepted Answer

Based on available 13F filings, UBS Group AG first reported a position in CLDX in 2024-Q3. They have held the position across 30 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	481,997	+62.3%	$17.9M	0.0%	$37.21	41
2026-Q1	Decreased	296,970	-9.0%	$9.4M	0.0%	$28.94	0
2025-Q4	Decreased	326,462	-21.6%	$8.9M	0.0%	$26.43	0
2025-Q3	Decreased	416,447	-50.5%	$10.8M	0.0%	$26.19	0
2025-Q2	Decreased	841,246	-42.7%	$17.1M	0.0%	$20.29	0
2025-Q1	Increased	1.5M	+276.7%	$26.6M	0.0%	$19.93	46
2024-Q4	Increased	389,797	+134.0%	$9.9M	0.0%	$25.12	45
2024-Q3	Increased	166,597	+3.7%	$5.7M	0.0%	$33.20	28